- Accession Number
One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes.
Drug Drug Description Amifampridine A voltage gated potassium channel blocker used to treat Lambert-Eaton myasthenic syndrome.
- Drugs & Drug Targets
Drug Target Type Amifampridine Arylamine N-acetyltransferase 1 enzyme Amifampridine Arylamine N-acetyltransferase 2 enzyme Amifampridine Potassium voltage-gated channel subfamily A member 1 target